Shield Therapeutics Balance Sheet
Shield Therapeutics's total assets for Q4 2025 were £65.24M, an increase of 5.06% from the previous quarter. GB:STX total liabilities were £80.32M for the fiscal quarter, a 4.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.